U.S. to Probe Reports of Antisemitic Incidents at Top Medical Schools
Lawyers from the Department of Health and Human Services have launched investigations of several medical schools, including ...
Trump’s China tariffs are likely to drive up drug prices and spur shortages
President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is l ikely to drive up the cost of generic ...
ONL Therapeutics Announces Multiple Presentations at Leading Ophthalmology Meetings
9th Military Vision Symposium on Novel Technology and Vision Restoration hosted by Harvard Medical School Department of Ophthalmology and Mass Eye and Ear, February 27-28, 2025, at the Starr Center ...
PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator Device in ALS
Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO, stated, “We are pleased to announce IRB approval for the CALM study, which allows us to commence enrollments shortly. Given the mechanisms ...
The Harvard Crimson10h
The Canceled HMS Panel Is a Failure of Empathy
Empathy should be our power — the ability to stand with people in their pain while fighting for their health. Our promise is to value the lives and health of others unequivocally. Our downfall is when ...
San Francisco Examiner23h
Silencing science: How Trump is reshaping US health
Medical researchers left to compile national data by hand, contraceptive guidelines deemed essential by doctors erased, and ...